AlphAIalphai — Financial news for AI agents
marketwatch.comAUG 281 min read$KODK

Eastman Kodak Co. stock underperforms Friday when compared to competitors

Eastman Kodak Co. (KODK) shares fell 4.54% to $9.04 on Friday, marking a second straight day of declines. The NASDAQ and Dow Jones also dropped, by 0.52% and 0.02% respectively.

Original reporting
marketwatch.com
Published Aug 28, 2026, 9:24 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 29, 2026, 2:08 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefMarket movers
Primary signal
$KODK
Bearish
medium confidence
Mentioned
$KODK
Relevance
4/10
alphai data visualization · based on marketwatch.com
Decision brief

The 30-second read

$KODKBearishLow
01

Why it matters

No new catalyst; price move aligns with overall market weakness.

02

Market read

Minor relevance; price decline reflects broader market sentiment rather than company‑specific news.

03

What to watch

Potential upcoming earnings or product announcements not yet disclosed could reverse the trend.

Relevance 4/10Novelty 2/10Timing: Friday

Background

The article reports Kodak's stock underperformance relative to peers on a weak trading day.

Company-level read

Ticker impact

$KODKBearishMedium confidence
Context

Shares fell 4.54% to $9.04 on Friday, marking a second consecutive day of losses.

Expected impact

Potential further short-term downside if market sentiment remains bearish.

Evidence & confidence

No specific catalyst was disclosed; the move appears driven by overall market decline.

Market effects

Sector

Kodak operates in imaging and chemicals; its weakness may hint at sector softness.

Regional

U.S. market decline reflected in Nasdaq and Dow indices.

Global

Limited, as the move is company‑specific without broader macro impact.

Counterpoint

What could challenge this read

If the price drop is purely market‑wide, a contrarian could view the dip as a buying opportunity.

Key entities

  • Company
    Eastman Kodak Co.

    U.S.-listed imaging and chemicals firm.

Read at source← All news

Related articles

AUG 13
$KODKMed

Kodak’s Transformed Business Has Improved for Four Straight Quarters

Eastman Kodak reported FY2026 Q2 revenue of $311 million, up $48 million year over year, and gross profit up $31 million (61%). GAAP net income was $17 million versus a $26 million net loss a year earlier. Kodak attributed the $43 million improvement to higher gross profit, lower interest expense and fewer impairments. Print revenue was $195 million; Advanced Materials and Chemicals $105 million.

petapixel.com6 min
SEP 7
$NVSHighAI 8/10

Why is Novartis stock sliding today?

Novartis AG stock fell 3.5% after its Phase III Lp(a)HORIZON trial for pelacarsen failed to meet its primary endpoint, despite lowering lipoprotein(a) levels. The Swiss Market Index dropped 1.2%, with Novartis as the primary drag. The selloff follows earlier negative trends and is amplified by macroeconomic challenges, including rising oil prices and ECB rate hike expectations.

investing.com2 min
SEP 7
$NVSMedAI 8/10

Novartis Shares Fall After Heart Drug Misses Target in Late-Stage Trial

Novartis shares dropped 3.2% after its experimental heart drug, pelacarsen, failed to meet its primary goal in a late-stage trial. The drug reduced Lp(a) levels but did not lower cardiovascular risk. Novartis licensed pelacarsen from Ionis Pharmaceuticals. Analysts note recent positive MS study results may offset the setback, but the company needs positive results from other drugs to justify recent acquisitions.

morningstar.com2 min
SEP 7
$MSTRMed

Who Is Phong Le? Strategy CEO Who Defended Selling Bitcoin

Phong Le, CEO of Nasdaq-listed Strategy (MSTR), defended selling 7,000 BTC at $60,000-$65,000, citing cost-of-capital decisions. The company later repurchased 4,603 BTC at ~$80,318. Le's approach contrasts with former CEO Michael Saylor's never-sell strategy, focusing on financial management and risk mitigation.

phemex.com3 min